Clinical Implications of Chronic Heart Failure Phenotypes Defined by Cluster Analysis-Reference-Cited by-同舟云学术

Clinical Implications of Chronic Heart Failure Phenotypes Defined by Cluster Analysis

Published:2014-10 Issue:17 Volume:64 Page:1765-1774
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Ahmad Tariq,Pencina Michael J.,Schulte Phillip J.,O’Brien Emily,Whellan David J.,Piña Ileana L.,Kitzman Dalane W.,Lee Kerry L.,O’Connor Christopher M.,Felker G. Michael

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference35 articles.

1. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC

2. Heart failure;Braunwald;JACC Heart Fail,2013

3. Personalized cardiovascular medicine and drug development: time for a new paradigm;Loscalzo;Circulation,2012

4. Systolic and diastolic heart failure: different phenotypes of the same disease?;De Keulenaer;Eur J Heart Fail,2007

5. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008‡

Cited by 206 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine Learning–Driven Phenogrouping and Cardiorespiratory Fitness Response in Metastatic Breast Cancer;JCO Clinical Cancer Informatics;2024-09

2. Unsupervised machine learning to identify subphenotypes among cardiac intensive care unit patients with heart failure;ESC Heart Failure;2024-08-19

3. Clinical Phenotypes and Outcomes of Patients with Left Ventricular Thrombus: An Unsupervised Cluster Analysis;Hellenic Journal of Cardiology;2024-08

4. Distinct Comorbidity Clusters in Patients With Acute Heart Failure;JACC: Heart Failure;2024-07

5. m6A epitranscriptomic modification of inflammation in cardiovascular disease;International Immunopharmacology;2024-06